Your browser doesn't support javascript.
loading
Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models.
Wang, Feng; Tsai, Jordan C; Davis, Jonathan H; Chau, Bryant; Dong, Jia; West, Sean M; Hogan, Jason M; Wheeler, Matthew L; Bee, Christine; Morishige, Winse; Cayton, Thomas; David-Brown, Donata; Zhang, Chengyue; Kozhich, Alexander; Sproul, Tim; Dollinger, Gavin; Rajpal, Arvind; Strop, Pavel.
Affiliation
  • Wang F; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Tsai JC; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Davis JH; Invenra, Inc, Madison, WI, USA.
  • Chau B; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Dong J; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • West SM; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Hogan JM; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Wheeler ML; Immuno-Oncology Research, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Bee C; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Morishige W; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Cayton T; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • David-Brown D; Bioanalytical Sciences, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Zhang C; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Kozhich A; Bioanalytical Sciences, Bristol-Myers Squibb, Princeton, NJ, USA.
  • Sproul T; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Dollinger G; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Rajpal A; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
  • Strop P; Protein Therapeutics and Biologics Lead Discovery, Bristol-Myers Squibb, Redwood City, CA, USA.
MAbs ; 12(1): 1685350, 2020.
Article in En | MEDLINE | ID: mdl-31856660
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / T-Lymphocytes / Protein Engineering / Antibodies, Bispecific / Rituximab Limits: Animals Language: En Journal: MAbs Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / T-Lymphocytes / Protein Engineering / Antibodies, Bispecific / Rituximab Limits: Animals Language: En Journal: MAbs Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States